CEBPE Gene

CEBPE — CCAAT/Enhancer Binding Protein Epsilon

Overview

CEBPE (CCAAT/Enhancer Binding Protein Epsilon) is a lineage-specific transcription factor that plays a critical role in terminal granulocyte differentiation and the regulation of innate immune responses. While primarily studied in the context of myeloid cell development, CEBPE has emerged as a protein of interest in [neurodegenerative disease](/diseases/neurodegeneration) research due to its involvement in [neuroinflammation](/mechanisms/neuroinflammation) — a central pathological feature of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other chronic neurodegenerative conditions. The protein regulates genes involved in inflammatory responses, microglial function, and cytokine production, making it a key player in the neuroimmune axis.

CEBPE — CCAAT/Enhancer Binding Protein Epsilon

Overview

CEBPE (CCAAT/Enhancer Binding Protein Epsilon) is a lineage-specific transcription factor that plays a critical role in terminal granulocyte differentiation and the regulation of innate immune responses. While primarily studied in the context of myeloid cell development, CEBPE has emerged as a protein of interest in [neurodegenerative disease](/diseases/neurodegeneration) research due to its involvement in [neuroinflammation](/mechanisms/neuroinflammation) — a central pathological feature of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other chronic neurodegenerative conditions. The protein regulates genes involved in inflammatory responses, microglial function, and cytokine production, making it a key player in the neuroimmune axis.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">CEBPE</th></tr>
<tr><td><b>Gene Symbol</b></td><td>CEBPE</td></tr>
<tr><td><b>Full Name</b></td><td>CCAAT/Enhancer Binding Protein Epsilon</td></tr>
<tr><td><b>Aliases</b></td><td>C/EBPε, CEBPE, CRP1</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>14q11.2</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>1053</td></tr>
<tr><td><b>OMIM ID</b></td><td>605348</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000092067</td></tr>
<tr><td><b>UniProt ID</b></td><td>Q15744</td></tr>
<tr><td><b>Protein Length</b></td><td>294 amino acids</td></tr>
<tr><td><b>Expression</b></td><td>Myeloid cells, microglia, brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Normal Function

Protein Structure

CEBPE belongs to the CCAAT/Enhancer Binding Protein (C/EBP) family of transcription factors, which share a characteristic structure:

• Basic region: DNA contact
• Leucine zipper: Dimerization

DNA Binding

CEBPE binds to specific DNA sequences:

• CAAT motif: Canonical C/EBP binding site (ATTGCGCAAT)
• Palindromic sites: Enhanced affinity for symmetric sequences
• Promoter/enhancer regions: Regulates target gene expression

Dimerization

Like other C/EBP proteins, CEBPE forms:

• Homodimers: CEBPE-CEBPE complexes
• Heterodimers: With CEBPα, CEBPβ, other family members
• Higher-order complexes: Larger transcriptional regulatory assemblies

Role in Myeloid Development

Granulocyte Differentiation

CEBPE is essential for terminal granulocyte differentiation:

Expression Pattern

CEBPE expression is restricted to:

| Cell Type | Expression Level |
|-----------|------------------|
| Myeloid progenitors | Low |
| Promyelocytes | High |
| Myelocytes | High |
| Metamyelocytes | Moderate |
| Neutrophils | Low |
| Eosinophils | Low |
| Microglia | Variable |

Target Genes in Myeloid Cells

CEBPE regulates genes critical for granulocyte function:

| Gene | Function |
|------|-----------|
| ELANE | Neutrophil elastase |
| PRTN3 | Proteinase 3 |
| MPO | Myeloperoxidase |
| CD177 | Neutrophil marker |
| S100A8/A9 | Calprotectin |

Role in Neuroinflammation

Microglial Expression

Microglia, the brain's resident immune cells, express CEBPE:

• Activation-dependent: Expression increases with activation
• Regional variation: Higher in certain brain regions
• Disease modification: Altered in neurodegeneration

Neuroinflammatory Pathways

CEBPE regulates inflammatory responses in the CNS:

Cytokine Regulation

• Pro-inflammatory cytokines: IL-1β, IL-6, TNF-α
• Anti-inflammatory cytokines: IL-10, TGF-β
• Chemokines: CCL2, CXCL8, CCL5

Inflammasome Modulation

CEBPE influences the NLRP3 inflammasome:

• Assembly: Regulates inflammasome component expression
• Activation: Modulates caspase-1 activity
• IL-1β processing: Controls mature IL-1β production

Neurodegenerative Disease Context

Alzheimer's Disease

In AD, CEBPE contributes to:

Parkinson's Disease

In PD, CEBPE is implicated in:

Molecular Mechanisms

Transcriptional Regulation

CEBPE regulates gene expression through:

Signaling Pathways

CEBPE integrates with multiple signaling pathways:

| Pathway | Interaction |
|---------|------------|
| TLR signaling | Regulates inflammatory response |
| JAK-STAT | Interferon-mediated activation |
| NF-κB | Cross-talk with inflammation |
| MAPK | Stress-activated signaling |

Cell-Type Specific Effects

In different CNS cell types:

• Neurons: Limited expression, indirect effects
• Astrocytes: Low expression, potential regulation
• Microglia: Primary functional expression
• Oligodendrocytes: Minimal expression

Disease Associations

Inflammatory Diseases

| Disease | CEBPE Association |
|---------|------------------|
| Autoimmune disorders | Altered expression |
| Inflammatory bowel disease | Variant associations |
| Rheumatoid arthritis | Dysregulated function |

Neurodegenerative Diseases

Alzheimer's Disease

• Elevated CEBPE in AD brain
• Correlates with disease severity
• Microglial-specific upregulation

Parkinson's Disease

• CEBPE in substantia nigra
• Modulates neuroinflammation
• Potential therapeutic target

ALS

• Altered myeloid response
• Microglial phenotype regulation
• Disease progression modifier

Research Models

In Vitro Models

• Cell lines: HL-60, THP-1, primary microglia
• Primary cells: Murine/human microglia
• iPSC-derived: Myeloid cells from patients

In Vivo Models

• Mouse models: Knockout, transgenic lines
• Zebrafish: Developmental studies
• Conditional models: Cell-type specific ablation

Key Findings from Models

• CEBPE knockout mice: Granulocyte differentiation defects
• Overexpression: Enhanced inflammatory response
• Microglial-specific modulation: Alters disease phenotypes

Therapeutic Implications

Targeting CEBPE

Modulating CEBPE has therapeutic potential:

Therapeutic Strategies

| Strategy | Approach | Status |
|----------|----------|--------|
| Gene therapy | Viral vector delivery | Preclinical |
| Small molecules | Pathway inhibitors | Research |
| Cell therapy | Modified microglia | Experimental |

Biomarker Potential

CEBPE as a biomarker:

• Inflammatory marker: Reflects neuroinflammatory state
• Disease progression: Correlates with severity
• Therapeutic response: Monitors treatment effect

Interaction Network

Protein Interactors

| Protein | Interaction Type |
|---------|------------------|
| CEBPα | Heterodimer formation |
| CEBPβ | Functional cooperation |
| PU.1 | Co-regulatory |
| SPI1 | Lineage factor cooperation |
| STAT3 | Signaling cross-talk |

Downstream Targets

• Cytokine genes (IL1B, IL6, TNF)
• Chemokine genes (CCL2, CXCL1)
• Inflammatory enzymes (COX2, iNOS)
• Antimicrobial effectors (defensins)

Signaling Molecules

• TLR adapters: MyD88, TRIF
• Kinases: MAPK family
• Transcription factors: NF-κB, AP-1

Genetic Variation

Polymorphisms

• Promoter variants: Affect expression levels
• Coding variants: Alter protein function
• Regulatory variants: Tissue-specific effects

Disease Associations

• Inflammatory disorders: Genetic susceptibility
• Infectious disease: Response to infection
• Neurodegeneration: Risk modification

Cross-Linking to Related Topics

Mechanisms

• [Neuroinflammation](/mechanisms/neuroinflammation) — Chronic brain inflammation
• [Microglial Activation](/mechanisms/microglial-activation) — Immune cell response
• [Cytokine Signaling in Neurodegeneration](/mechanisms/cytokine-signaling-neurodegeneration)

Related Genes

• [CEBPA](/genes/cebpa) — C/EBP alpha
• [CEBPB](/genes/cebbp) — C/EBP beta
• [SPI1](/genes/spi1) — PU.1 transcription factor

Related Proteins

• [NF-κB](/proteins/nf-kb) — Inflammatory transcription factor
• [IL-1β](/proteins/il-1-beta) — Pro-inflammatory cytokine

Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD and neuroinflammation
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD and inflammation
• [ALS](/diseases/amyotrophic-lateral-sclerosis) — Neuroinflammation in ALS
• [Microglia-related diseases](/diseases/microglial-disorders)

Research Directions

Current Understanding

• CEBPE is a lineage-specific transcription factor
• Regulates granulocyte and microglial function
• Modulates neuroinflammatory responses
• Potential therapeutic target

Emerging Areas

Future Questions

• What drives CEBPE dysregulation in disease?
• Can targeting CEBPE improve outcomes?
• What is the balance of protective vs harmful effects?

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Microglial Activation](/mechanisms/microglial-activation)
• [Innate Immunity in CNS](/mechanisms/innate-immunity-cns)

External Links

• [Ensembl: ENSG00000092067](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000092067)
• [NCBI Gene: CEBPE](https://www.ncbi.nlm.nih.gov/gene/?term=CEBPE)
• [GeneCards: CEBPE](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEBPE)
• [OMIM: CEBPE](https://omim.org/search?search=CEBPE)
• [UniProt: CEBPE](https://www.uniprot.org/uniprotkb/Q15744)

References